Allergic Broncho-Pulmonary Aspergillosis (ABPA) is an allergic reaction that occurs in some individuals with asthma or cystic fibrosis when their lungs become hypersensitive to a fungus called Aspergillus fumigatus. This condition causes inflammation in the lungs and airways, leading to recurrent asthma attacks, worsening lung function, and, in some cases, lung damage if not properly managed.
Symptoms of ABPA can mimic those of asthma or lung infections, making it difficult to diagnose initially. Common symptoms include:
In some cases, individuals may also experience fatigue and general weakness.
ABPA is caused by an immune system response to inhaling Aspergillus spores, a common mold found in soil, dust, and decaying plant matter. People with asthma or cystic fibrosis are more susceptible to developing ABPA because their airways are more prone to inflammation.
Diagnosing ABPA involves a combination of clinical assessments, lung imaging (such as a chest X-ray or CT scan), and blood tests for elevated IgE levels (indicating an allergic response).
The main goals of treating ABPA are to control lung inflammation, reduce allergic reactions, and prevent further lung damage. Treatment options include:
Early diagnosis and appropriate management are crucial in preventing long-term lung damage caused by ABPA.
If you’re experiencing symptoms of Allergic Broncho-Pulmonary Aspergillosis (ABPA) or have concerns about your respiratory health, don’t wait for symptoms to worsen. Dr. A.K. Mandal specializes in diagnosing and managing ABPA and other respiratory conditions.
Our Location
Expert Pulmonology Care Conveniently located to Serve Your Needs.